Will Biopharma Companies Shun Vaccine R&D In A New Pandemic?
Forbes: Drug Truths
APRIL 11, 2024
Only biopharma could have combated Covid-19; no other industry has the capacity to do so. When the world was in crisis, this industry responded. If need be, it will again, despite the financial consequences.
Let's personalize your content